The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

LS-187187     (2Z)-2-(amino-hydroxy- methylidene)-4,7...

Synonyms:
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Minomycin

 

Psychiatry related information on Minomycin

 

High impact information on Minomycin

 

Chemical compound and disease context of Minomycin

 

Biological context of Minomycin

 

Anatomical context of Minomycin

 

Associations of Minomycin with other chemical compounds

 

Gene context of Minomycin

 

Analytical, diagnostic and therapeutic context of Minomycin

References

  1. A trial of minocycline given after exposure to prevent gonorrhea. Harrison, W.O., Hooper, R.R., Wiesner, P.J., Campbell, A.F., Karney, W.W., Reynolds, G.H., Jones, O.G., Holmes, K.K. N. Engl. J. Med. (1979) [Pubmed]
  2. Minocycline for symptomatic neurosyphilis in patients allergic to penicillin. De Maria, A., Solaro, C., Abbruzzese, M., Primavera, A. N. Engl. J. Med. (1997) [Pubmed]
  3. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Chen, M., Ona, V.O., Li, M., Ferrante, R.J., Fink, K.B., Zhu, S., Bian, J., Guo, L., Farrell, L.A., Hersch, S.M., Hobbs, W., Vonsattel, J.P., Cha, J.H., Friedlander, R.M. Nat. Med. (2000) [Pubmed]
  4. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Zhu, S., Stavrovskaya, I.G., Drozda, M., Kim, B.Y., Ona, V., Li, M., Sarang, S., Liu, A.S., Hartley, D.M., Wu, d.u. .C., Gullans, S., Ferrante, R.J., Przedborski, S., Kristal, B.S., Friedlander, R.M. Nature (2002) [Pubmed]
  5. Minocycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion. Cho, K.O., La, H.O., Cho, Y.J., Sung, K.W., Kim, S.Y. J. Neurosci. Res. (2006) [Pubmed]
  6. Minocycline protects basal forebrain cholinergic neurons from mu p75-saporin immunotoxic lesioning. Hunter, C.L., Quintero, E.M., Gilstrap, L., Bhat, N.R., Granholm, A.C. Eur. J. Neurosci. (2004) [Pubmed]
  7. Central and peripheral minocycline suppresses motor activity in rats. Kofman, O., van Embden, S., Alpert, C., Fuchs, I. Pharmacol. Biochem. Behav. (1993) [Pubmed]
  8. Black thyroid : Report of an autopsy case. Tsokos, M., Schröder, S. Int. J. Legal Med. (2006) [Pubmed]
  9. Minocycline-associated tooth discoloration in young adults. Poliak, S.C., DiGiovanna, J.J., Gross, E.G., Gantt, G., Peck, G.L. JAMA (1985) [Pubmed]
  10. Letter: Minocycline activity against tetracycline-resistant Staphylococcus aureus. Leigh, D.A. Lancet (1975) [Pubmed]
  11. Minocycline compared with doxycycline in the treatment of nongonococcal urethritis and mucopurulent cervicitis. Romanowski, B., Talbot, H., Stadnyk, M., Kowalchuk, P., Bowie, W.R. Ann. Intern. Med. (1993) [Pubmed]
  12. Minocycline-induced cell-mediated hypersensitivity pneumonitis. Guillon, J.M., Joly, P., Autran, B., Denis, M., Akoun, G., Debré, P., Mayaud, C. Ann. Intern. Med. (1992) [Pubmed]
  13. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Yrjänheikki, J., Tikka, T., Keinänen, R., Goldsteins, G., Chan, P.H., Koistinaho, J. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  14. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Tilley, B.C., Alarcón, G.S., Heyse, S.P., Trentham, D.E., Neuner, R., Kaplan, D.A., Clegg, D.O., Leisen, J.C., Buckley, L., Cooper, S.M., Duncan, H., Pillemer, S.R., Tuttleman, M., Fowler, S.E. Ann. Intern. Med. (1995) [Pubmed]
  15. Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease. Wang, X., Zhu, S., Drozda, M., Zhang, W., Stavrovskaya, I.G., Cattaneo, E., Ferrante, R.J., Kristal, B.S., Friedlander, R.M. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  16. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Du, Y., Ma, Z., Lin, S., Dodel, R.C., Gao, F., Bales, K.R., Triarhou, L.C., Chernet, E., Perry, K.W., Nelson, D.L., Luecke, S., Phebus, L.A., Bymaster, F.P., Paul, S.M. Proc. Natl. Acad. Sci. U.S.A. (2001) [Pubmed]
  17. Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Power, C., Henry, S., Del Bigio, M.R., Larsen, P.H., Corbett, D., Imai, Y., Yong, V.W., Peeling, J. Ann. Neurol. (2003) [Pubmed]
  18. Minocycline and black thyroid. Billano, R.A., Ward, W.Q., Little, W.P. JAMA (1983) [Pubmed]
  19. Diversity of melanoma plasma membrane proteinases: inhibition of collagenolytic and cytolytic activities by minocycline. Zucker, S., Lysik, R.M., Ramamurthy, N.S., Golub, L.M., Wieman, J.M., Wilkie, D.P. J. Natl. Cancer Inst. (1985) [Pubmed]
  20. Inflammation is detrimental for neurogenesis in adult brain. Ekdahl, C.T., Claasen, J.H., Bonde, S., Kokaia, Z., Lindvall, O. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  21. Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS. Zhang, W., Narayanan, M., Friedlander, R.M. Ann. Neurol. (2003) [Pubmed]
  22. Thyroid gland pigmentation and minocycline therapy. Gordon, G., Sparano, B.M., Kramer, A.W., Kelly, R.G., Iatropoulos, M.J. Am. J. Pathol. (1984) [Pubmed]
  23. Treatment of recurrent thyroid cysts by injection of tetracycline or minocycline. Lee, J.K., Tai, F.T., Lin, H.D., Chou, Y.H., Kaplan, M.M., Ching, K.N. Arch. Intern. Med. (1989) [Pubmed]
  24. Regulation of cytoplasmic calcium concentration in tetracycline-treated osteoclasts. Donahue, H.J., Iijima, K., Goligorsky, M.S., Rubin, C.T., Rifkin, B.R. J. Bone Miner. Res. (1992) [Pubmed]
  25. Symptomatic hepatic cysts: treatment with single-shot injection of minocycline hydrochloride. Cellier, C., Cuenod, C.A., Deslandes, P., Auroux, J., Landi, B., Siauve, N., Barbier, J.P., Frija, G. Radiology. (1998) [Pubmed]
  26. HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis. Reveille, J.D., Alarcón, G.S., Fowler, S.E., Pillemer, S.R., Neuner, R., Clegg, D.O., Mikhail, I.S., Trentham, D.E., Leisen, J.C., Bluhm, G., Cooper, S.M., Duncan, H., Tuttleman, M., Heyse, S.P., Sharp, J.T., Tilley, B. Arthritis Rheum. (1996) [Pubmed]
  27. Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion. Fox, C., Dingman, A., Derugin, N., Wendland, M.F., Manabat, C., Ji, S., Ferriero, D.M., Vexler, Z.S. J. Cereb. Blood Flow Metab. (2005) [Pubmed]
  28. Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction. Giuliani, F., Hader, W., Yong, V.W. J. Leukoc. Biol. (2005) [Pubmed]
  29. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. Sriram, K., Miller, D.B., O'Callaghan, J.P. J. Neurochem. (2006) [Pubmed]
  30. Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and IkappaBalpha degradation in a stimulus-specific manner in microglia. Nikodemova, M., Duncan, I.D., Watters, J.J. J. Neurochem. (2006) [Pubmed]
  31. Tetracycline-resistant Ureaplasma urealyticum: a cause of persistent nongonococcal urethritis. Stimson, J.B., Hale, J., Bowie, W.R., Holmes, K.K. Ann. Intern. Med. (1981) [Pubmed]
  32. Inhibition of autoimmune encephalomyelitis by a tetracycline. Popovic, N., Schubart, A., Goetz, B.D., Zhang, S.C., Linington, C., Duncan, I.D. Ann. Neurol. (2002) [Pubmed]
  33. Minocycline-induced hyperpigmentation masquerading as alkaptonuria in individuals with joint pain. Suwannarat, P., Phornphutkul, C., Bernardini, I., Turner, M., Gahl, W.A. Arthritis Rheum. (2004) [Pubmed]
  34. Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac/DIABLO. Scarabelli, T.M., Stephanou, A., Pasini, E., Gitti, G., Townsend, P., Lawrence, K., Chen-Scarabelli, C., Saravolatz, L., Latchman, D., Knight, R., Gardin, J. J. Am. Coll. Cardiol. (2004) [Pubmed]
 
WikiGenes - Universities